רספרים

Država: Izrael

Jezik: hebrejščina

Source: Ministry of Health

Aktivna sestavina:

SULPHAMETHOXAZOLE; TRIMETHOPRIM

Dostopno od:

TEVA PHARMACEUTICAL INDUSTRIES LTD, ISRAEL

Koda artikla:

J01EE01

Farmacevtska oblika:

תרחיף

Sestava:

SULPHAMETHOXAZOLE 200 MG / 5 ML; TRIMETHOPRIM 40 MG / 5 ML

Pot uporabe:

פומי

Tip zastaranja:

מרשם נדרש

Izdeluje:

TEVA PHARMACEUTICAL INDUSTRIES LTD, ISRAEL

Terapevtska skupina:

SULFAMETHOXAZOLE AND TRIMETHOPRIM

Terapevtsko območje:

SULFAMETHOXAZOLE AND TRIMETHOPRIM

Terapevtske indikacije:

Treatment of urinary tract infections due to susceptible strains of the following organisms: - Escherichia coli - Klebsiella - Enterobacter - Proteus mirabilis - Proteus vulgaris - Proteus morganii. Treatment of acute otitis media in children due to susceptible strains of Haemophilus influenzae or Streptococcus pneumoniae. To date there are limited data available as to the safety of repeated use of Resprim in infants under 2 years of age. Resprim is not indicated for prophylactic or prolonged administration in otitis media at any age. Treatment of acute exacerbations of chronic bronchitis due to susceptible strains of Haemophilus influenzae or Streptococcus pneumoniae. Treatment of enteritis caused by susceptible strains of Shigella flexneri and Shigella sonnei. Resprim is also indicated in the treatment of documented Pneumocystis carinii pneumonitis.

Datum dovoljenje:

2012-01-31